COMMUNIQUÉS West-GlobeNewswire

CervoMed Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15/05/2024
- CervoMed on track to complete enrollment in 2Q 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies (DLB); topline data expected in 4Q 2024- - Completed up [...]
Sagimet Biosciences Reports First Quarter 2024 Financial Results and Provides Corporate Updates
15/05/2024
Denifanstat Phase 2b FASCINATE-2 clinical data to be presented as an oral presentation at the EASL International Liver Congress 2024 taking place in Milan, Italy from June 5-8, 2024 End-of-Phase 2 meeting with U.S. Food [...]
Reviva Announces Enrollment Update for Open Label Extension Study Evaluating Brilaroxazine in Schizophrenia
15/05/2024
– 358 enrolled and 223 patients currently on treatment across sites in the USA, Europe and Asia – – Brilaroxazine is generally well tolerated to date in patients with acute and stable schizophrenia – – Topline data from [...]
Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
15/05/2024
Media Release Confirmed complete response in a patient with metastatic breast cancer refractory to several lines of therapy achieved during combination treatment with 90mg efti and paclitaxel Ongoing complete response [...]
American Oncology Network Advances Karyogram Segmentation and Increases the Speed to Results with New A.I. Software
15/05/2024
The AON Central Lab is recognized as the first laboratory in the world to use this technology, which decreases analysis time. FORT MYERS, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- American Oncology Network (AON) (Nasdaq: [...]
Kane Biotech Expands its Wound Care Portfolio with Patented Schultz Biofilm Wound Map
15/05/2024
Named in Honour of the late Dr. Greg Schultz, Former Professor Emeritus at the University of Florida and Chief Science Officer of Kane Biotech WINNIPEG, Manitoba, May 15, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX [...]
Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member
15/05/2024
JERUSALEM, May 15, 2024 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”), a leader in the development of orally delivered peptides and small therapeutic proteins, today announced the [...]
Phathom Pharmaceuticals to Present VOQUEZNA® (vonoprazan) Data at DDW 2024 Annual Meeting
15/05/2024
First oral presentation of Phase 3 data evaluating the investigational use of VOQUEZNA® in Non-Erosive Reflux Disease (NERD) 1 New research on Erosive gastroesophageal reflux disease (GERD) demonstrating high health [...]
Scorpius Holdings Achieves Major Milestone with cGMP Facility Validation for Microbial Manufacturing
15/05/2024
Gaining operating efficiency through transition to an internal environmental monitoring team DURHAM, N.C., May 15, 2024 (GLOBE NEWSWIRE) -- Scorpius Holdings, Inc (NYSE American: SCPX) , (“Scorpius” or the “Company”), [...]
iCAD Reports Financial Results for First Quarter Ended March 31, 2024
15/05/2024
NASHUA, N.H., May 15, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, today [...]
PharmaTher’s Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine
15/05/2024
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, announced today Sairiyo Therapeutics Inc. (“Sairiyo”), a [...]
DiagnaMed’s BRAIN AGE® Brain Health AI Platform Targeting Multi-Billion Digital Brain Health Market
15/05/2024
TORONTO, May 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), a healthcare technology company focused on brain health using AI, is commercializing its [...]
Solid Biosciences Provides First Quarter 2024 Business Update and Financial Results
15/05/2024
— Received Rare Pediatric Disease and Orphan Drug Designation for Duchenne muscular dystrophy (Duchenne) gene therapy candidate SGT-003 with patient dosing in Phase 1/2 trial expected Q2 2024 — — Company entered into [...]
Major shareholder announcement – BlackRock, Inc.
15/05/2024
ANNOUNCEMENT NO. 266 Major shareholder announcement Major shareholder announcement – BlackRock, Inc. Pursuant to Section 30 of the Capital Markets Act, it is hereby announced that BlackRock, Inc. has informed ChemoMetec [...]
Brand New Technology “LPA Synapse” by LQpay Delivers Reliable, Workflow-Integrated Payments for Dental Practices
15/05/2024
FORT LAUDERDALE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- LQpay , the leading end-to-end patient payments provider, proudly launches LPA Synapse. Building upon the Company’s existing AI and automation technology and [...]
Philips announces exchange ratio for 2023 dividend
15/05/2024
May 15, 2024 Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2023 is 1 new common share for every 29.2684 existing common shares. [...]
Posting of Annual Report & Notice of AGM - Total Voting Rights
15/05/2024
May 15, 2024 Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Posting of Annual Report & Notice of AGM Total Voting Rights Biodexa Pharmaceuticals PLC (NASDAQ: BDRX), a clinical stage biopharmaceutical [...]
VIRBAC: Communiqué précisant les modalités de mise à disposition ou de consultation des documents préparatoires à l’assemblée générale mixte ordinaire et extraordinaire
15/05/2024
Les actionnaires de la société VIRBAC sont avisés qu’une assemblée générale mixte ordinaire et extraordinaire se tiendra le vendredi 21 juin 2024 à 9 heures , dans les bâtiments de VIRBAC direction, 13ème rue L.I.D., [...]
Roche announces FDA approval of one of the first HPV self-collection solutions in the U.S., expanding access and screening options to help eliminate cervical cancer
15/05/2024
More than half of all U.S. cervical cancer patients are underscreened 1 , which makes reducing barriers to sample collection and increasing access to screenings crucial to ultimately helping eliminate this deadly [...]

Pages